These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8854350)

  • 1. Risk factors of cholestasis in very low-birth-weight infants.
    Wu TJ; Teng RJ; Yau KI
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1996; 37(4):278-82. PubMed ID: 8854350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intrahepatic cholestasis associated with parenteral nutrition in premature infants.
    Beale EF; Nelson RM; Bucciarelli RL; Donnelly WH; Eitzman DV
    Pediatrics; 1979 Sep; 64(3):342-7. PubMed ID: 113770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized controlled trial of early parenteral nutrition cycling to prevent cholestasis in very low birth weight infants.
    Salvador A; Janeczko M; Porat R; Sekhon R; Moewes A; Schutzman D
    J Pediatr; 2012 Aug; 161(2):229-33.e1. PubMed ID: 22424948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Parenteral nutrition-associated cholestasis in premature babies: risk factors and predictors.
    Hsieh MH; Pai W; Tseng HI; Yang SN; Lu CC; Chen HL
    Pediatr Neonatol; 2009 Oct; 50(5):202-7. PubMed ID: 19856863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection and cholestasis in neonates with intestinal resection and long-term parenteral nutrition.
    Sondheimer JM; Asturias E; Cadnapaphornchai M
    J Pediatr Gastroenterol Nutr; 1998 Aug; 27(2):131-7. PubMed ID: 9702641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retrospective Dual-Center Study of Parenteral Nutrition-Associated Cholestasis in Premature Neonates: 15 Years' Experience.
    Yan W; Hong L; Wang Y; Feng Y; Lu L; Tao Y; Wu J; Ruan H; Tang Q; Cai W
    Nutr Clin Pract; 2017 Jun; 32(3):407-413. PubMed ID: 28135431
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperalimentation-induced cholestasis. Increased incidence and severity in premature infants.
    Pereira GR; Sherman MS; DiGiacomo J; Ziegler M; Roth K; Jacobowski D
    Am J Dis Child; 1981 Sep; 135(9):842-5. PubMed ID: 6792907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrauterine growth restriction impacts tolerance to total parenteral nutrition in extremely low birth weight infants.
    Baserga MC; Sola A
    J Perinatol; 2004 Aug; 24(8):476-81. PubMed ID: 15141267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ursodeoxycholic acid (UDCA) therapy in very-low-birth-weight infants with parenteral nutrition-associated cholestasis.
    Chen CY; Tsao PN; Chen HL; Chou HC; Hsieh WS; Chang MH
    J Pediatr; 2004 Sep; 145(3):317-21. PubMed ID: 15343182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial infection: the main cause of acute cholestasis in newborn infants receiving short-term parenteral nutrition.
    Wolf A; Pohlandt F
    J Pediatr Gastroenterol Nutr; 1989 Apr; 8(3):297-303. PubMed ID: 2496214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total parenteral nutrition-associated cholestasis in infants: clinical and liver histologic studies.
    Chou YH; Yau KI; Hsu HC; Chang MH
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1993; 34(4):264-71. PubMed ID: 8213156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural history of conjugated bilirubin trajectory in neonates following parenteral nutrition cessation.
    Mangalat N; Bell C; Graves A; Imseis EM
    BMC Pediatr; 2014 Dec; 14():298. PubMed ID: 25492029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholestasis, bronchopulmonary dysplasia, and lipid profile in preterm infants receiving MCT/ω-3-PUFA-containing or soybean-based lipid emulsions.
    Skouroliakou M; Konstantinou D; Agakidis C; Delikou N; Koutri K; Antoniadi M; Karagiozoglou-Lampoudi T
    Nutr Clin Pract; 2012 Dec; 27(6):817-24. PubMed ID: 22878361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cochrane Review: Prophylactic phototherapy for preventing jaundice in preterm or low birth weight infants.
    Okwundu CI; Okoromah CA; Shah PS
    Evid Based Child Health; 2013 Jan; 8(1):204-49. PubMed ID: 23878128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of cholestasis in infants with very low birth weight.
    Owings E; Georgeson K
    Semin Pediatr Surg; 2000 May; 9(2):96-102. PubMed ID: 10807232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cholestasis in a neonatal intensive care unit.
    Brown DC; Halliday HL; McClure G
    Ir Med J; 1991 Jun; 84(2):56-7. PubMed ID: 1910021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ursodeoxycholic acid therapy for intractable total parenteral nutrition-associated cholestasis in surgical very low birth weight infants.
    Al-Hathlol K; Al-Madani A; Al-Saif S; Abulaimoun B; Al-Tawil K; El-Demerdash A
    Singapore Med J; 2006 Feb; 47(2):147-51. PubMed ID: 16435058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intestinal failure-associated liver disease in surgical infants requiring long-term parenteral nutrition.
    Bishay M; Pichler J; Horn V; Macdonald S; Ellmer M; Eaton S; Hill S; Pierro A
    J Pediatr Surg; 2012 Feb; 47(2):359-62. PubMed ID: 22325390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early inflammatory markers for prediction of cholestasis in very-low-birth-weight infants.
    DeMauro SB; Kilpatrick LE; Gerdes JS; Abbasi S
    Neonatology; 2012; 102(3):229-34. PubMed ID: 22907525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased cholestasis with enteral instead of intravenous protein in the very low-birth-weight infant.
    Brown MR; Thunberg BJ; Golub L; Maniscalco WM; Cox C; Shapiro DL
    J Pediatr Gastroenterol Nutr; 1989 Jul; 9(1):21-7. PubMed ID: 2506323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.